Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Philip J. Mitchelmore
Observed names:
P Mitchelmore,
P. Mitchelmore,
Phil Mitchelmore,
Philip J Mitchelmore,
Philip Mitchelmore
Institutions:
University of Exeter,
Royal Devon & Exeter NHS Foundation Trust,
Royal Devon and Exeter Hospital,
MRC Centre for Medical Mycology,
Royal Devon University Healthcare NHS Foundation Trust
Observed institutions:
University of Exeter,
Royal Devon & Exeter NHS Foundation Trust,
Musgrove Park Hospital,
Royal Devon and Exeter Hospital,
Torbay Hospital,
Exeter Hospital,
MRC Centre for Medical Mycology,
Royal Devon University Healthcare NHS Foundation Trust
show all 8
ORCID:
0000-0002-7850-3068
Observed ORCID:
0000-0002-7850-3068
OpenAlex ID:
A5068694817
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2021
·
Eugenia Abaleke
, Mustafa Abbas
, et al.
·
The Lancet
·
533
PDF
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial
2021
·
Obbina Abani
, Ali Abbas
, et al.
·
The Lancet
·
493
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2022
·
Obbina Abani
, Ali Abbas
, et al.
·
The Lancet
·
369
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis
2022
·
Obbina Abani
, Ali Abbas
, et al.
·
The Lancet
·
324
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2021
·
Obbina Abani
, Ali Abbas
, et al.
·
The Lancet
·
290
Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial
2023
·
Obbina Abani
, Ali Abbas
, et al.
·
The Lancet
·
129
British Thoracic Society guideline for the use of long-term macrolides in adults with respiratory disease
2020
·
David Smith
, Ingrid Du Rand
, et al.
·
Thorax
·
65
PDF
Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2023
·
O Abani
, A Abbas
, et al.
·
The Lancet Diabetes & Endocrinology
·
41
PDF
Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial
2024
·
Saul N Faust
, Richard Haynes
, et al.
·
The Lancet Child & Adolescent Health
·
39
PDF
British Thoracic Society guideline for the use of long-term macrolides in adults with respiratory disease
2020
·
David Smith
, Ingrid A Du Rand
, et al.
·
BMJ Open Respiratory Research
·
39
PDF
Novel point-of-care biomarker combination tests to differentiate acute bacterial from viral respiratory tract infections to guide antibiotic prescribing: a systematic review
2021
·
Henry C. Carlton
, Jelena Savović
, et al.
·
Clinical Microbiology and Infection
·
37
PDF
Molecular epidemiology of Pseudomonas aeruginosa in an unsegregated bronchiectasis cohort sharing hospital facilities with a cystic fibrosis cohort
2017
·
Philip J Mitchelmore
, Joanna Randall
, et al.
·
Thorax
·
16
PDF
Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2024
·
RECOVERY Collaborative Group
, Peter Sandercock
, et al.
·
Nature Communications
·
11
PDF
A Bispecific Monoclonal Antibody Targeting Psl and PcrV for Chronic Pseudomonas Aeruginosa Infection in Patients With Bronchiectasis: Results From a Randomized, Double-Blind Placebo-Controlled Trial (GREAT-2)
2025
·
M.B. Long
, R.C. Hull
, et al.
·
American Journal of Respiratory and Critical Care Medicine
·
9
Risk of Bacterial Transmission in Bronchiectasis Outpatient Clinics
2018
·
Philip Mitchelmore
, Catherine Wilson
, et al.
·
Current Pulmonology Reports
·
7
PDF
Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial
2025
·
O. Abani
, A. Abbas
, et al.
·
EClinicalMedicine
·
5
Phage Therapy Administration Route, Regimen, and Need for Supplementary Antibiotics in Patients with Chronic Suppurative Lung Disease
2023
·
Jessica Williams
, James Severin
, et al.
·
PHAGE
·
5
Culture-independent multilocus sequence typing of Pseudomonas aeruginosa for cross-infection screening
2021
·
Philip J. Mitchelmore
, Nicholas J. Withers
, et al.
·
Diagnostic Microbiology and Infectious Disease
·
5
Understanding risk of poor outcomes in adults hospitalised with respiratory syncytial virus infection: evidence from a multicentre UK cohort
2026
·
Tommaso Morelli
, Martha Purcell
, et al.
·
Thorax
·
4
Copper-driven mutualism of Candida albicans and Staphylococcus aureus interkingdom biofilms
2026
·
Iana Kalinina
, Roberto Vazquez-Muñoz
, et al.
·
Microbiology
·
3
Candida in the lung: Fact, fiction, friend or foe?
2026
·
Philip Mitchelmore
, Seána Duggan
·
PLoS Pathogens
·
3
PDF
A bispecific monoclonal antibody targeting Pseudomonas aeruginosa in bronchiectasis: results from the GREAT-2 trial
2025
·
Merete Bridget Long
, Rebecca C Hull
, et al.
·
3
Culture-independent Multilocus sequence typing screening for Haemophilus influenzae cross-infection in non-cystic fibrosis bronchiectasis
2024
·
Catherine R Wilson
, Philip J Mitchelmore
, et al.
·
Diagnostic Microbiology and Infectious Disease
·
3
S113 An Epidemiological Review of Strains of Pseudomonas aeruginosa in a Non-Cystic Fibrosis Bronchiectasis Cohort
2015
·
P Mitchelmore
, A Brown
, et al.
·
Thorax
·
3
PDF
Understanding Infection, Viral Exacerbation and Respiratory Symptoms at Admission-Longitudinal (UNIVERSAL) study: a prospective observational cohort study protocol
2025
·
Tommaso Morelli
, Martha Purcell
, et al.
·
BMJ Open
·
2
Show more works
View as search
Works count:
56
Citation count:
2,446
H-index:
12
I10-index:
13
Year
Topic
Type
